1. Home
  2. CYBN vs LTRX Comparison

CYBN vs LTRX Comparison

Compare CYBN & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • LTRX
  • Stock Information
  • Founded
  • CYBN 2019
  • LTRX 1989
  • Country
  • CYBN Canada
  • LTRX United States
  • Employees
  • CYBN N/A
  • LTRX N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • LTRX Computer Communications Equipment
  • Sector
  • CYBN Health Care
  • LTRX Telecommunications
  • Exchange
  • CYBN Nasdaq
  • LTRX Nasdaq
  • Market Cap
  • CYBN 176.5M
  • LTRX 186.8M
  • IPO Year
  • CYBN N/A
  • LTRX 2000
  • Fundamental
  • Price
  • CYBN $6.07
  • LTRX $5.25
  • Analyst Decision
  • CYBN Strong Buy
  • LTRX Strong Buy
  • Analyst Count
  • CYBN 3
  • LTRX 4
  • Target Price
  • CYBN $85.00
  • LTRX $4.63
  • AVG Volume (30 Days)
  • CYBN 673.9K
  • LTRX 437.6K
  • Earning Date
  • CYBN 11-12-2025
  • LTRX 11-06-2025
  • Dividend Yield
  • CYBN N/A
  • LTRX N/A
  • EPS Growth
  • CYBN N/A
  • LTRX N/A
  • EPS
  • CYBN N/A
  • LTRX N/A
  • Revenue
  • CYBN N/A
  • LTRX $122,923,000.00
  • Revenue This Year
  • CYBN N/A
  • LTRX $4.81
  • Revenue Next Year
  • CYBN N/A
  • LTRX $11.85
  • P/E Ratio
  • CYBN N/A
  • LTRX N/A
  • Revenue Growth
  • CYBN N/A
  • LTRX N/A
  • 52 Week Low
  • CYBN $4.81
  • LTRX $1.91
  • 52 Week High
  • CYBN $13.88
  • LTRX $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 45.10
  • LTRX 67.05
  • Support Level
  • CYBN $5.72
  • LTRX $4.42
  • Resistance Level
  • CYBN $6.52
  • LTRX $4.67
  • Average True Range (ATR)
  • CYBN 0.30
  • LTRX 0.27
  • MACD
  • CYBN 0.05
  • LTRX 0.00
  • Stochastic Oscillator
  • CYBN 38.48
  • LTRX 80.58

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

Share on Social Networks: